Brief Information of the Cell Line and Protein
Cell Line ID: CL000298 , H4-II-E
Synonyms
H-4-II-E
H4IIE
Category Cancer cell line
Organism
Rattus norvegicus (Rat)
Cellosaurus ID
CVCL_0284
Protein ID: PT00870 , Glucocorticoid receptor
Gene Name NR3C1
Organism Rattus norvegicus, Rat
Protein Classification Transcription factor
Uniprot ID P06536
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000298  Protein ID: PT00870
 
Compound ID Compound Name Compound Formula
CP0070809
CCI-18781
   Show/Hide
C25H31F3O5S
 1
1
EC50 = 0.76 nM
   TI
   LI
   LO
   TS
CP0393622
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C33H33NO6S2
 1
1
EC50 = 18.7 nM
   TI
   LI
   LO
   TS
CP0238565
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C29H31F2NO4S2
 1
1
EC50 = 27 nM
   TI
   LI
   LO
   TS
CP0035186
(10S,11S,14S,15S,17R)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one
   Show/Hide
C29H35NO2
 1
1
IC50 = 1.94 nM
   TI
   LI
   LO
   TS
CP0416607
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H33FN2O4
 1
1
IC50 = 3.2 nM
   TI
   LI
   LO
   TS
CP0416614
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H34N2O4
 1
1
IC50 = 3.23 nM
   TI
   LI
   LO
   TS
CP0380981
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H36FN3O3S
 1
1
IC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0444548
N-[2-[[benzyl(methyl)amino]methyl]-3-(4-fluoro-2-methoxyphenyl)-5-propan-2-yl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C28H32FN3O3S
 1
1
IC50 = 10.6 nM
   TI
   LI
   LO
   TS
CP0400170
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H35FN4O4S
 1
1
IC50 = 13.3 nM
   TI
   LI
   LO
   TS
CP0416609
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyrimidin-2-ylsulfanylethanone
   Show/Hide
C32H35FN4O3S
 1
1
IC50 = 14.3 nM
   TI
   LI
   LO
   TS
CP0410986
N-[2-[[benzyl(methyl)amino]methyl]-5-tert-butyl-3-(4-fluoro-2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C29H34FN3O3S
 1
1
IC50 = 14.4 nM
   TI
   LI
   LO
   TS
CP0387981
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C31H35NO4S
 1
1
IC50 = 19.2 nM
   TI
   LI
   LO
   TS
CP0432716
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]thiazolo[5,4-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O4S2
 1
1
IC50 = 24.1 nM
   TI
   LI
   LO
   TS
CP0400172
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O3S2
 1
1
IC50 = 24.1 nM
   TI
   LI
   LO
   TS
CP0400173
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 24.3 nM
   TI
   LI
   LO
   TS
CP0428604
2-(1,3-benzoxazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O4S
 1
1
IC50 = 31.6 nM
   TI
   LI
   LO
   TS
CP0400175
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H36N4O4S
 1
1
IC50 = 33.8 nM
   TI
   LI
   LO
   TS
CP0432419
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-yloxyethanone
   Show/Hide
C37H38FN3O4
 1
1
IC50 = 44.7 nM
   TI
   LI
   LO
   TS
CP0400160
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-ylsulfanylethanone
   Show/Hide
C38H39FN2O3S
 1
1
IC50 = 52.5 nM
   TI
   LI
   LO
   TS
CP0400171
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O3S2
 1
1
IC50 = 54.7 nM
   TI
   LI
   LO
   TS
CP0380940
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H37N3O3S2
 1
1
IC50 = 57.3 nM
   TI
   LI
   LO
   TS
CP0416608
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-yloxyethanone
   Show/Hide
C38H39FN2O4
 1
1
IC50 = 58 nM
   TI
   LI
   LO
   TS
CP0413727
N-[5-fluoro-3-(4-fluoro-2-methoxyphenyl)-2-methyl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C17H16F2N2O3S
 1
1
IC50 = 63.4 nM
   TI
   LI
   LO
   TS
CP0047174
(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
   Show/Hide
C21H28O5
 1
1
IC50 = 65.4 nM
   TI
   LI
   LO
   TS
CP0380980
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-isoquinolin-1-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 65.4 nM
   TI
   LI
   LO
   TS
CP0413728
N-[3-(3-chlorophenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C15H13ClN2O2S
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0410217
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H40N4O3S
 1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CP0416612
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)oxyethanone
   Show/Hide
C36H39FN4O4
 1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CP0400177
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H39N3O3S
 1
1
IC50 = 82.3 nM
   TI
   LI
   LO
   TS
CP0385331
2-(1,3-benzothiazol-2-yloxy)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O4S
 1
1
IC50 = 84 nM
   TI
   LI
   LO
   TS
CP0385328
2-[2-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-oxoethyl]sulfanyl-3H-quinazolin-4-one
   Show/Hide
C36H37FN4O4S
 1
1
IC50 = 86.5 nM
   TI
   LI
   LO
   TS
CP0416610
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-ylsulfanylethanone
   Show/Hide
C36H38N4O3S
 1
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
CP0401463
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O5S
 1
1
IC50 = 135 nM
   TI
   LI
   LO
   TS
CP0446952
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfanyl]ethanone
   Show/Hide
C33H45N3O3S2
 1
1
IC50 = 135 nM
   TI
   LI
   LO
   TS
CP0410216
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H39FN4O3S
 1
1
IC50 = 174 nM
   TI
   LI
   LO
   TS
CP0400174
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H37N3O3S
 1
1
IC50 = 225 nM
   TI
   LI
   LO
   TS
CP0387984
(8S,9S,10R,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H33NO4S2
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0145473
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O4S
 1
1
IC50 = 235 nM
   TI
   LI
   LO
   TS
CP0434913
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C38H42N4O3S
 1
1
IC50 = 258 nM
   TI
   LI
   LO
   TS
CP0429171
N-[2-benzyl-3-(4-fluoro-2-methoxyphenyl)-5-propan-2-yl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C26H27FN2O3S
 1
1
IC50 = 292 nM
   TI
   LI
   LO
   TS
CP0385432
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H33NO4S
 1
1
IC50 = 361 nM
   TI
   LI
   LO
   TS
CP0385431
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-pyridin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H31NO4S
 1
1
IC50 = 707 nM
   TI
   LI
   LO
   TS
CP0427353
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H34N2O5S
 1
1
IC50 = 740 nM
   TI
   LI
   LO
   TS
CP0409039
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H46N4O3S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0513116
N-[3-(2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C16H16N2O3S
 1
1
IC50 = 1180 nM
   TI
   LI
   LO
   TS
CP0416932
N-[3-(5-chloro-2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C16H15ClN2O3S
 1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0424441
2-[3,5-dibromo-4-[4-methoxy-2-(3-methylbenzoyl)-5-propan-2-ylphenoxy]phenyl]acetic acid
   Show/Hide
C26H24Br2O5
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS